Roy Lester Freeman - 30 Jun 2023 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Milton H. Werner, attorney-in-fact
Issuer symbol
IKT
Transactions as of
30 Jun 2023
Transactions value $
$0
Form type
4
Filing time
05 Jul 2023, 21:11:09 UTC
Previous filing
28 Jun 2022
Next filing
18 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (right to buy) Award $0 +6.67K $0.00 6.67K 30 Jun 2023 Common Stock 6.67K $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest on the earlier of June 30, 2024 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.